Inventor · disambiguated record
David I. Stirling
Also filed as: STIRLING DAVID · STIRLING DAVID I · STIRLING DAVID L
46 granted patents·15 pending applications·5,499 citations·filing 1982–2016
99Inventor score
Top patents by PatentIndex Score
61 records- 0199US6555554B2Isoindolines, method of use, and pharmaceutical compositionsCELGENE CORP·Filed 2001·Granted Apr 29, 2003·245 cites·17 claims
- 0299US6476052B1Isoindolines, method of use, and pharmaceutical compositionsCELGENE CORP·Filed 2000·Granted Nov 5, 2002·295 cites·28 claims
- 0399US6335349B1Substituted 2(2,6-dioxopiperidin-3-yl)isoindolinesCELGENE CORP·Filed 2000·Granted Jan 1, 2002·301 cites·23 claims
- 0499US6316471B1Isoindolines, method of use, and pharmaceutical compositionsCELGENE CORP·Filed 2000·Granted Nov 13, 2001·334 cites·26 claims
- 0599US6281230B1Isoindolines, method of use, and pharmaceutical compositionsCELGENE CORP·Filed 2000·Granted Aug 28, 2001·400 cites·26 claims
- 0699US5874448ASubstituted 2-(2,6 dioxo-3-fluoropiperidin-3-yl)-isoindolines and method of reducing TNFα levelsCELGENE CORP·Filed 1997·Granted Feb 23, 1999·285 cites·23 claims
- 0799US5798368ATetrasubstituted 2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolines and method of reducing TNFα levelsCELGENE CORP·Filed 1996·Granted Aug 25, 1998·305 cites·8 claims
- 0898US6458810B1Pharmaceutically active isoindoline derivativesMULLER GEORGE·Filed 2000·Granted Oct 1, 2002·281 cites·18 claims
- 0998US6395754B1Substituted 2-(2,6-dioxopiperidin-3-yl)- phthalimides and 1-oxoisoindolines and method of reducing TNFα levelsCELGENE CORP·Filed 1998·Granted May 28, 2002·296 cites·12 claims
- 1098US6380239B1Substituted 1-oxo- and 1,3-dioxoisoindoline and method of reducing inflammatory cytokine levelsCELGENE CORP·Filed 2000·Granted Apr 30, 2002·253 cites·18 claims
- 1198US5955476ASubstituted 2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoindolines and method of reducing inflammatory cytokine levelsCELGENE CORP·Filed 1998·Granted Sep 21, 1999·267 cites·23 claims
- 1297US8158653B2Pharmaceutical compositions of 1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)-4-amino isoindolineMULLER GEORGE W·Filed 2006·Granted Apr 17, 2012·39 cites·2 claims
- 1397US7498171B2Modulation of stem and progenitor cell differentiation, assays, and uses thereofANTHROGENESIS CORP·Filed 2003·Granted Mar 3, 2009·160 cites·14 claims
- 1497US5635517AMethod of reducing TNFα levels with amino substituted 2-(2,6-dioxopiperidin-3-yl)-1-oxo-and 1,3-dioxoisoindolinesCELGENE CORP·Filed 1996·Granted Jun 3, 1997·643 cites·10 claims
- 1596US7709502B2Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and 1-oxoisoindolinesCELGENE CORP·Filed 2006·Granted May 4, 2010·24 cites·3 claims
- 1696US5908850AMethod of treating attention deficit disorders with d-threo methylphenidateCELGENE CORP·Filed 1997·Granted Jun 1, 1999·211 cites·4 claims
- 1796US5801195AImmunotherapeutic aryl amidesCELGENE CORP·Filed 1994·Granted Sep 1, 1998·121 cites·16 claims
- 1895US7629360B2Methods for the treatment of cachexia and graft v. host diseaseCELGENE CORP·Filed 2005·Granted Dec 8, 2009·21 cites·5 claims
- 1995US7119106B2Pharmaceutical compositions of 1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindolineCELGENE CORP·Filed 2003·Granted Oct 10, 2006·53 cites·7 claims
- 2095US6046221AImmunotherapeutic aryl amidesCELGENE CORP·Filed 1998·Granted Apr 4, 2000·108 cites·7 claims
- 2195US5736570AImmunotherapeutic aryl amidesCELGENE CORP·Filed 1996·Granted Apr 7, 1998·114 cites·12 claims
- 2294US7041680B2(R) and (S) isomers of substituted 2-(2,6-dioxopiperidin-3-yl) phthalimides and 1-oxoisoindolines and methods of using the sameCELGENE CORP·Filed 2002·Granted May 9, 2006·38 cites·12 claims
- 2393US5346828AStereoisomeric enrichment of 2-amino-3-hydroxy-3-phenylpropionic acids using d-threonine aldolaseCELGENE CORP·Filed 1992·Granted Sep 13, 1994·55 cites·17 claims
- 2492US5169780AEnantiomeric enrichment and stereoselective synthesis of chiral aminesCELGENE CORP·Filed 1990·Granted Dec 8, 1992·89 cites·18 claims
- 2591US7459466B2Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and -1-oxoisoindolines and method of reducing TNFα levelsCELGENE CORP·Filed 2005·Granted Dec 2, 2008·12 cites·9 claims
- 2691US6284780B1Immunotherapeutic aryl amidesCELGENE CORP·Filed 2000·Granted Sep 4, 2001·32 cites·18 claims
- 2791US5703098AImmunotherapeutic imides/amidesCELGENE CORP·Filed 1996·Granted Dec 30, 1997·113 cites·20 claims
- 2890US6762195B2Pharmaceutically active isoindoline derivativesCELGENE CORP·Filed 2002·Granted Jul 13, 2004·29 cites·22 claims
- 2989US8288415B2Pharmaceutical compositions of 3-(4-amino-1-oxoisoindolin-2yl)-piperidine-2,6-dioneMULLER GEORGE W·Filed 2009·Granted Oct 16, 2012·7 cites·6 claims
- 3088US5733756ALactams and processes for stereoselective enrichment of lactams, amides, and estersCELGENE CORP·Filed 1996·Granted Mar 31, 1998·46 cites·20 claims
- 3188US5300437AEnantiomeric enrichment and stereoselective synthesis of chiral aminesCELGENE CORP·Filed 1992·Granted Apr 5, 1994·120 cites·16 claims
- 3288US4950606AEnantiomeric enrichment and stereoselective synthesis of chiral aminesCELGENE CORP·Filed 1989·Granted Aug 21, 1990·89 cites·20 claims
- 3383US6844359B2Substituted imidesCELGENE CORP·Filed 2002·Granted Jan 18, 2005·14 cites·21 claims
- 3483US6429221B1Substituted imidesCELGENE CORP·Filed 1994·Granted Aug 6, 2002·38 cites·18 claims
- 3582US8889411B2Modulation of stem and progenitor cell differentiation, assays, and uses thereofHARIRI ROBERT J·Filed 2009·Granted Nov 18, 2014·4 cites·11 claims
- 3672US7005438B2Pharmaceutically active isoindoline derivativesCELGENE CORP·Filed 2003·Granted Feb 28, 2006·3 cites·5 claims
- 3770US2010093797A1Methods For Treatment Of Cognitive And Menopausal Disorders With D-Threo MethylphenidateZELDIS JEROME B·Filed 2009·Application pending·0 cites
- 3869US5071976ANovel heteropolysaccharideCELGENE CORP·Filed 1988·Granted Dec 10, 1991·13 cites·3 claims
- 3969US4594324AMicrobiological process for oxidizing organic compoundsNAT RES DEV·Filed 1982·Granted Jun 10, 1986·22 cites·14 claims
- 4069US2006030587A1Method of treating attention deficit disorders with d-threo methylphenidateCELGENE CORP·Filed 2005·Application pending·0 cites
- 4169US2005119307A1Method of treating attention deficit disorders with D-threo methylphenidateCELGENE CORP·Filed 2004·Application pending·0 cites
- 4266US2011201645A1Method Of Treating Attention Deficit Disorders With D-Threo MethylphenidateZEITLIN ANDREW L·Filed 2011·Application pending·0 cites
- 4365US4652527AProcess for culturing methylophilus methylotrophusCELANESE CORP·Filed 1984·Granted Mar 24, 1987·17 cites·5 claims
- 4465US2014187584A1Substituted 2-(2,6-Dioxopiperidin-3-yl)-phthalimides and -1-Oxoisoindolines and Method of Reducing TNFalpha LevelsCELGENE CORP·Filed 2014·Application pending·0 cites
- 4562US2013030021A1Substituted 2-(2,6-Dioxopiperidin-3-yl)-phthalimides and 1-Oxoisoindolines and Method of Reducing TNFalpha LevelsCELGENE CORP·Filed 2012·Application pending·0 cites
- 4661US9546131B2Substituted biaryl alkyl amidesBIOTHERYX INC·Filed 2014·Granted Jan 17, 2017·0 cites·27 claims
- 4761US7834033B2Methods for treating cancer using 3-[1,3dioxo-4-benzamidoisoindolin-2-yl]-2,6-dioxo-5-hydroxypiperidineCELGENE CORP·Filed 2005·Granted Nov 16, 2010·0 cites·16 claims
- 4861US7329761B2Substituted imidesCELGENE CORP·Filed 2004·Granted Feb 12, 2008·0 cites·9 claims
- 4961US2013053414A1Methods for treatment of cognitive and menopausal disorders with d-threo methylphenidateZELDIS JEROME B·Filed 2012·Application pending·0 cites
- 5059US2016096818A1Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and -1-oxoisoindolines and method of reducing tnfalpha levelsCELGENE CORP·Filed 2015·Application pending·0 cites
Showing the top 50 of 61 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when David I. Stirling files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →